Ten patients with pure detrusor instability were treated in a prospective fashion with, transdermal scopolamine. Seventy percent of patients experienced moderate to severe untoward symptoms requiring discontinuation of medication. Three of 10 patients (30 %) demonstrated subjective improvement although only 1 was able to tolerate the medication. No objective change in detrusor instability was demonstrated.
ASJC Scopus subject areas